{"id":242066,"date":"2012-10-09T07:18:35","date_gmt":"2012-10-09T07:18:35","guid":{"rendered":"http:\/\/www.eugenesis.com\/donald-paul-lombardi-m-d-joins-the-oncology-institute-of-hope-and-innovation\/"},"modified":"2012-10-09T07:18:35","modified_gmt":"2012-10-09T07:18:35","slug":"donald-paul-lombardi-m-d-joins-the-oncology-institute-of-hope-and-innovation","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/donald-paul-lombardi-m-d-joins-the-oncology-institute-of-hope-and-innovation.php","title":{"rendered":"Donald Paul Lombardi, M.D. Joins The Oncology Institute of Hope and Innovation"},"content":{"rendered":"<p><p>    The Oncology    Institute of Hope and Innovation welcomes Dr. Donald    Paul Lombardi.  <\/p>\n<p>    Downey, California (PRWEB) October 08, 2012  <\/p>\n<p>    He completed his internship and residency in Internal Medicine    at the University of Michigan Hospitals, where he won the House    Officer Research Award. He did his Medical Oncology Fellowship    at the National    Cancer Institute in Bethesda, MD, and did postgraduate    fellowships in Molecular Genetics and Molecular Biology at the    National    Institutes of Health.  <\/p>\n<p>    He was on the faculty at Washington University School of    Medicine (then ranked #2 by the US News & World    Report), where he specialized in breast and genitourinary    cancers at the Siteman Cancer Center at Barnes-Jewish Hospital    (then ranked #6 among US hospitals).  <\/p>\n<p>    Because of his commitment to the cancer research, he enrolled    into a Masters Degree Program in Clinical and Translational    Investigation at the Kellogg School of Science at Technology at    The Scripps Research Institute and Scripps Translational    Science Institute in La Jolla, CA. Utilizing start-of-the-art    genomics, proteomics and metabolomics, Dr. Lombardi focused his    laboratory work on high fat diets and how they contribute to    tumor aggressiveness. He will be coming from Scripps Cancer    Center and Scripps Mercy Hospital.  <\/p>\n<p>    Dr. Lombardi has received numerous honors and awards throughout    his career, including a Physician-Scientist Training Award from    the Department of Defense for U.S. Army Medical Research and    Materiel Command's Breast Cancer Research Program; a    Developmental Project\/Career Development Award at the    University of Texas SPORE in Lung Cancer; a Clinical Associate    Physician (CAP) Award from the National Institutes of Health    (NIH); and, most recently, a KL2 Clinical Scholarship from the    NIH.  <\/p>\n<p>    Dr. Lombardi has a very personal connection with cancer    treatment. His mother, sister, and grandmother had breast cancer and his    father had testicular cancer.  <\/p>\n<p>    When I see a patient, I see the individual as a person with    cancer first, and then as an oncologist treating that patient    second. I think that I bring a passion to cancer care that    comes from my own emotional response to having close family    members go through cancer treatment.  <\/p>\n<p>    Dr. Lombardi will be joining eleven other physicians on staff    at The Oncology    Institute of Hope and Innovation starting October 15th,    2012.  <\/p>\n<p>    About The Oncology Institute:  <\/p>\n<\/p>\n<p>Here is the original post:<br \/>\n<a target=\"_blank\" href=\"http:\/\/news.yahoo.com\/donald-paul-lombardi-m-d-joins-oncology-institute-020019508.html;_ylt=A2KLOzLBz3NQ1SIA1Hn_wgt.\" title=\"Donald Paul Lombardi, M.D. Joins The Oncology Institute of Hope and Innovation\">Donald Paul Lombardi, M.D. Joins The Oncology Institute of Hope and Innovation<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> The Oncology Institute of Hope and Innovation welcomes Dr.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biochemistry\/donald-paul-lombardi-m-d-joins-the-oncology-institute-of-hope-and-innovation.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577469],"tags":[],"class_list":["post-242066","post","type-post","status-publish","format-standard","hentry","category-biochemistry"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/242066"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=242066"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/242066\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=242066"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=242066"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=242066"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}